18 -19
May

Venture Capital & Private Equity Boston

Investment Challenges and Opportunities in Emerging Biotech Markets

Le Meridien Cambridge Boston

What to expect

Timely information, interactive format

Real insights are shared in conversations, not lectures. That’s why our unique roundtable format guarantees real learning and ensures you only attend discussions that deliver value to you. rnrnJoin as many as four roundtable discussions, each with up to 20 other subject experts, networking with top-level peers in an informal, relaxed and sociable environment.

Our Facilitators

Our panel of facilitators plays a key role in shaping the agenda for the day. Whilst we’re busy connecting with the best industry experts, take a look at our facilitators.

Carolina Alarco

Founder and Principal Bio Strategy Advisors

Claire Elizabeth Smith

Partner SpringTide Ventures

Christina Ansted

Senior Managing Partner RCP Venture Capital

Goldi Kaul

Vice President, Head of External Alternative CMC Development Boehringer Ingelheim

Michal Preminger

Stratetic Advisor efferson Life Sciences

Neil Kairen

Managing Director Biotech Value Advisors

Nelly Viseux

Vice President, Cell Therapies Development, Manufacturing, Supply & Quality Regeneron

Robert Gabriel

Board Member, Managing Partner Ashur Capital

Stephanie Oestreich

Managing Director Myeloma Investment Fund

Tomasz H. Zastawny, PhD, DSc

Chief Executive Officer Armora Biosciences

Our Past Facilitators

Our panel of facilitators plays a key role in shaping the agenda for the day. Whilst we’re busy connecting with the best industry experts, take a look at our facilitators.

Alex Zisson

Managing Director H.I.G. Capital

David Sherris

CEO Attivare Therapeutics

Session – Next Generation OV and New Combinational Approaches for Treatment of Solid Tumors 
Dr. Sherris has over 30 years’ experience in translational medicine involving basic research, pharmaceutics and diagnostics.  Dr. Sherris has been a successful serial entrepreneur developing biotechnology companies from the ground up, devising corporate strategy, enacting programs and carrying companies through funding and acquisition.  Dr. Sherris prides himself as a “roll up your sleeves” CEO, entrepreneur, business development officer, drug developer and scientist, not simply a delegator. Dr. Sherris has worked with venture capital companies where he has both advised and raised finances for biotech companies.  Dr. Sherris has been employed by pharmaceutical and biotechnology companies to manage external (academic groups and contract research organizations) and internal (directly manage, augment and expand internal scientific programs) research and development. Dr. Sherris has been a frequently invited guest speaker at biopharmaceutical business and scientific conferences, a published author and holder of patents in a wide range of therapeutic areas including oncology, ophthalmology, dermatology, neurology, gene therapy and infectious disease.  Dr. Sherris has held positions of increasing responsibility in public and private companies. Dr. Sherris has developed drugs from the bench to the clinic, partnered technologies to pharmaceutical companies and raised capital for companies at the triple digit million dollar levels.

Christina Ansted

Senior Managing Partner RCP Venture Capital

Giovanni Abbadessa

Chief Medical Officer ModeX Therapeutics

Govinda Bhisetti

Vice President and Head of Computational Chemistry Cellarity

Huseyin Mehmet

Executive Director, New Ventures University of Massachusetts Medical School

Huseyin Mehmet is a drug hunter and research scientist with >35 years’ experience in basic and clinical academic research and in pharmaceutical / biotechnology drug discovery. He received his PhD from the Medical Research Council in the UJ and went on to work at University College London, the Imperial Cancer Research Fund (now Cancer Research UK), Cold Spring Harbor Lab, USA and then took a faculty position at Imperial College School of Medicine. There his work focused on cerebral hypoxic ischemic injury in neonates and he was part of the team that developed mild hypothermia for the treatment of birth asphyxia. In 2006 Huseyin left the UK to join Merck and Co, in the USA. He worked in biomarker discovery, target identification and several drug discovery programs up to clinical candidate selection. For the next few years, he took on roles with increasing responsibility in several biotech companies and also consulted for a number of start-up companies working with prominent VC firms (e.g. Atlas Ventures and Versant Ventures). Since 2021, Huseyin has led the New Ventures team in the BRIDGE Innovation and Business Development office at UMass Chan Medical School, where he is responsible for the scientific partnering of intellectual property arising from faculty discoveries.

Michael Janes

Co Founder – Chief Revenue Officer RCP Venture Capital

Mohamed Kassam

Head, Bioinformatics Zifo

Prateek Katti

Investor Newpath Partners

Our Agenda

Private Equity, Venture Capital & Strategic Partnerships
How Private Equity and Venture Capital Are Shaping the Future of Biotech Investment Strategies Across the Full Drug Discovery and Development Spectrum

Stephanie Oestreich,
Managing Director,
Myeloma Investment Fund

Private Equity, Venture Capital & Strategic Partnerships
The Role of Machine Learning and AI-Powered Data Platforms in Shaping Future Investment Decisions and Portfolio Strategy

Private Equity, Venture Capital & Strategic Partnership
Emerging Modalities, Emerging Markets: Identifying High-Impact Investment Opportunities in Cutting-Edge Biotech

Claire Smith,
Partner,
Springtide Ventures

Private Equity, Venture Capital & Strategic Partnerships
Building Capital-Efficient Biotech: Leveraging AI & Virtual Models to Replace Infrastructure

Tomasz Zastawny,
Chief Executive Officer,
Armora Biosciences

Private Equity, Venture Capital & Strategic Partnerships
Pre-Commercial Readiness as the New Gatekeeper of Capital in Biotech: How early commercial strategy is reshaping valuation, partnership, and financing decisions

Chairperson: Christina Ansted,
Senior Managing Partner,
RCP Venture Capital

Private Equity, Venture Capital & Strategic Partnerships

Chairperson: Goldi Kaul,
Vice President, Head of External Alternative CMC Development,
Boehringer Ingelheim

Private Equity, Venture Capital & Strategic Partnerships
How VCs Are Pacing Capital amid Longer Timelines?

Private Equity, Venture Capital & Strategic Partnerships
Is Private Equity Quietly Becoming the Dominant Force in Life Sciences?

Private Equity, Venture Capital & Strategic Partnerships
Portfolio Value Creation Beyond the Check: How Life Sciences VCs Drive Pre-Inflection Success?

Robert Gabriel,
Board Member, Managing Partner,
Ashur Capital

Private Equity, Venture Capital & Strategic Partnerships
How Early Is “Too Early” to Invest in Manufacturing?

Private Equity, Venture Capital & Strategic Partnerships

Capital in Transition: Navigating Opportunity and Risk in Today’s Life Sciences Market

Engage in Real Conversations That Matter

Our unique roundtable format fosters meaningful dialogue—not lectures—so you gain actionable insights from every discussion.rnrnChoose up to four roundtable sessions, each limited to 20 participants, and connect with senior-level peers in a relaxed, collaborative setting.

Choose Your Venture Date

*First name

*Last name

*Company name

*Job Title

*First line of address

*City

*Postcode/Zipcode

*Country

*Work Email

*Direct Line

*Mobile/Cell

*What are your 3 main strategic challenges?

Do you have dietary requirements?

YesNo

If yes please indicate

***We Highly Recommend to Use Google Chrome, Safari or Firefox Browser.

I hereby consent Proventa International to collect and share my provided contact details to other delegates and sponsors attending the same event I am attending.

I agree to Proventa International using this information to contact me about relevant content, products, and services. You may unsubscribe at any time. For more information, check out our Privacy Policy.

Further Information

Interested in attending this virtual roundtable or running your own? Drop us a message today and we will get in touch

Here To Help

Need help registering your team? Just get in touch and a member of the team will be happy to help.

Europe

USA East

USA West

Webinars

Europe

R&D

Investment Dinners & Spotlights

Venture Capital & Private Equity

Venture Capital & Private Equity Boston

<img class="lazy" decoding="async" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%2012%2016'%3E%3C/svg%3E" data-src="https://proventainternational.com/wp-content/uploads/2020/12/location.png" >Le Meridien Cambridge Boston

Timely information, interactive format

Our Facilitators

Carolina Alarco

Claire Elizabeth Smith

Christina Ansted

Goldi Kaul

Michal Preminger

Neil Kairen

Nelly Viseux

Robert Gabriel

Stephanie Oestreich

Tomasz H. Zastawny, PhD, DSc

Our Past Facilitators

Alex Zisson

David Sherris

Christina Ansted

Giovanni Abbadessa

Govinda Bhisetti

Huseyin Mehmet

Michael Janes

Mohamed Kassam

Prateek Katti

Our Agenda

Day 1 : 18th of May, 2026

Registration And Welcome

Opening Keynote Presentation

Roundtable Roundtable Tracks

Refreshment Break

Networking / 1-1 Meetings

Roundtable Roundtable Tracks

Roundtable Roundtable Tracks

Networking Lunch

Networking / 1-1 Meetings

Networking / 1-1 Meetings

Afternoon Keynote Presentation Revvity Signals

Roundtable Roundtable Tracks

Afternoon Refreshment Break

PANEL DISCUSSION

Drinks & Canapes Reception

Day 2 : 19th of May, 2026

Registration And Welcome

Opening Keynote Presentation

Roundtable

Refreshment Break

Networking / 1-1 Meetings

Roundtable Roundtable Tracks

Roundtable Roundtable Tracks

Networking Lunch

Networking / 1-1 Meetings

Networking / 1-1 Meetings

Afternoon Keynote Presentation

Roundtable Roundtable Tracks

Afternoon Refreshment Break

PANEL DISCUSSION

Drinks & Canapes Reception

Engage in Real Conversations That Matter

You had been successfully registered.

Further Information

Here To Help

Select days you wish to attend You can add multiple days

VAT Excluded

Select days you wish to attend You can add multiple days

Pass includes:

VAT Excluded

About You

Your Address

About Your Company

This is required field*

Bone/Osteoporosis

Immunology

Le Meridien Cambridge Boston